Peter Thiel-backed firm takes majority stake in a brain computer interface start-up

ATAI Life Sciences, a Peter Thiel-backed company developing psychedelic drugs to treat mental health, has taken a majority stake in U.S. firm Psyber.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.